Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol Reactivation Mismatch for PTSD
NCT03652922Phase 4Unknown
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, single-blind trial in post-traumatic stress disorder (PTSD) comparing Propranolol with Placebo (2 arms). Primary endpoint: PTSD Checklist for DSM-5 Change Score at 7 weeks. Status: unknown.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03652922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03652922.